FEM1A Knockout C2C12 Cell Line
Cat.No.:
EDC07555
Species:
Mouse
Cell Name:
C2C12
Gene:
FEM1A
Gene ID:
14154
Size:
1×10⁶cells
FEM1A Knockout C2C12 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07555 |
|---|---|
| Product Name | FEM1A Knockout C2C12 Cell Line |
| Species | Mouse |
| Cell Line | C2C12 |
| Cellosaurus ID | CVCL_0188 |
| Cell Line Synonyms | C2c12, C2-C12, C12 |
| Gene ID | |
| Gene | FEM1A |
| Associated Diseases | Non-tumor |
| Digestion Time | ~2 min |
| Morphology | Adherent |
| Passage Ratio | 1:3~1:4 |
| Complete Culture Medium | DMEM+10% FBS |
| Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: C2C12 | STR Info (Cell bank) Cell Line: C2C12 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| 1-1 | 10 | |||
| 1-2 | 16 | |||
| 2-1 | 9 | |||
| 3-2 | 14 | |||
| 4-2 | 19.3 | 19.3 | ||
| 5-5 | 15 | 15 | ||
| 6-4 | 18 | 18 | ||
| 6-7 | 12 | 12 | ||
| 7-1 | 26 | |||
| 8-1 | 17 | |||
| 11-2 | 16 | |||
| 12-1 | 16 | 16 | ||
| 13-1 | 17.1 | |||
| 15-3 | 25.3 | 25.3 | ||
| 17-2 | 15 | |||
| 18-3 | 16 | 16 | ||
| 19-2 | 12 | |||
| X-1 | 25 | 26 | 25 | 26 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying FEM1A function, FEM1A Knockout C2C12 Cell Line or FEM1A overexpression C2C12 Cell Line?
The choice depends on whether you are studying FEM1A's role as a Cullin-2 (CUL2)-RING E3 ligase substrate receptor or its functions in skeletal muscle and protein quality control. The Knockout line is the standard tool for asking whether FEM1A is required for these processes — FEM1A is one of three Fem1 family proteins (FEM1A, FEM1B, FEM1C) characterized as CRL2 (CUL2-RING ligase) substrate receptors recognizing C-terminal degron motifs (particularly C-terminal arginine-ending degrons); FEM1A has been implicated in skeletal muscle biology. Overexpression is useful for studying FEM1A gain-of-function effects.
For muscle biology research, the EDITGENE Fem1a Knockout in C2C12 is highly relevant — C2C12 is a murine myoblast cell line capable of differentiating into multinucleated myotubes, providing a physiologically relevant context for skeletal muscle Fem1a study. FEM1B, FEM1C paralog expression analysis aids interpretation given functional overlap. Rescue with wild-type or substrate-binding-deficient FEM1A enables structure-function studies. The knockout is valuable for studying CRL2-FEM1A-mediated protein quality control and emerging C-terminal degron biology.
What are the application scenarios for this model?
Primary applications:
• CRL2-FEM1A substrate stability: candidate substrate protein stability analysis in FEM1A-null cells given CRL2-FEM1A E3 ligase function.
• Myogenic differentiation: MyoD, myogenin, MHC expression and myotube formation analysis given C2C12's myogenic capacity.
• C-terminal degron biology: assessment of C-terminal R/arginine-ending degron substrate accumulation in the absence of FEM1A.
• Fem1 family comparative studies: FEM1B, FEM1C expression analysis to interpret FEM1A-specific functions.
EDITGENE recommends this C2C12-based model for researchers investigating skeletal muscle Fem1a biology and CRL2-FEM1A-mediated protein quality control.
Is this FEM1A Knockout C2C12 Cell Line compatible with overexpression rescue experiments?
Yes. FEM1A rescue experiments require attention to ankyrin repeat architecture:
• Construct design: use a codon-modified FEM1A sequence with a small C-terminal tag (FLAG, HA). FEM1A has N-terminal ankyrin repeats (substrate recognition) and C-terminal regions — preserve all elements.
• Substrate-binding-deficient rescue: ankyrin repeat mutations disrupt C-terminal degron substrate binding.
• CRL2 scaffolding: rescue with FEM1A retains CRL2 complex assembly — rescue interpretation considers CUL2-elongin BC complex.
• Functional readout: rescue should restore CRL2-FEM1A substrate degradation.
C2C12-specific considerations:
• C2C12 is a murine myoblast cell line (C3H mouse origin) — the principal continuous skeletal muscle cell model for myogenesis, muscle differentiation, and metabolic research.
• Lentiviral transduction is supported with moderate efficiency; characterize myoblast markers (MyoD, Myf5) and respond to differentiation cues (low-serum medium) to drive myotube formation.
• C2C12 differentiation into multinucleated myotubes is a hallmark feature useful for studying muscle-relevant gene function.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download